Welcome and Introduction Faculty Panel
Thromboprophylaxis Across the Arteriovenous Spectrum-Focus on VTE Prevention, New Mechanisms, and Emerging Agents for “Red (Arterial) States” and “Blue (Venous) States” Stavros V. Konstantinides, MD
Mechanisms of Atherothrombotic Events as a Basis for Preventive Therapies-Focus on Antithrombotic Strategies and Factor Xa Inhibition Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI
Acute Coronary Syndrome (ACS)-Achieving Effective Secondary Prevention of Thrombosis-Related Events: Factor Xa Inhibition and The Optimal Balance Between Anti-Ischemic Efficacy and Bleeding Risk Reduction John H. Alexander, MD, MHS, FACC
Challenges in Managing Bleeding Risk Across the Spectrum of Arterial and Venous Thromboprophylaxis: Strategies for Mitigating Adverse Events in Atrial Fibrillation, ACS, and VTE Prophylaxis-Current Options and Emerging Opportunities Sunil V. Rao, MD
Question and Answer Session Faculty Panel